Only 152 CMOs are equipped to manufacture cell and gene therapies: GlobalData
Production bottlenecks are the major obstacle to large-scale commercial manufacture once more advanced therapy medicinal products…
Author
Junshi Biosciences gets US FDA Breakthrough Therapy Designation for Toripalimab to treat…
It is the first anti-PD-1 antibody from China to receive BTD
Granules gets USFDA nod for ADHD drug dexmethylphenidate HCl extended-release capsules
The drug will be manufactured at the Granules manufacturing facility in Chantilly, Virginia
Pfizer and BioNTech to potentially supply EU with 200 mn doses of COVID-19 vaccine candidate
The proposed agreement also has an option to purchase additional 100 million doses, with deliveries starting by the end of 2020,…
Contact tracing inside infected cells offer new clues about SARS-CoV-2 virus: Study
The findings of this research could lead to better diagnostics or new treatments, as well as helping to explain what makes this…
Global pharma’s two battles – supply continuity and COVID-19 vaccine
Richa Mahindru, Domain Leader, Pharma and Life Sciences Practice, and Ishani Jain, Member, Pharma and Life Sciences Practice…
Informing payers and patients of biological therapy advantages can strengthen biosimilars market
Patients are unaware of the cost savings and payers are unclear if they can replace the reference biologics with the biosimilar…
Cipla Health forays into antifungal product category
Launches Clocip Clotrimazole Absorbent Dusting Powder and Clocip Clotrimazole Cream to treat fungal skin infections
GSK gets US FDA approval for Trelegy Ellipta to treat asthma, COPD
Trelegy is the first single inhaler triple therapy approved for the maintenance treatment of both asthma and COPD
Zydus Cadila gets tentative USFDA nod for empagliflozin and linagliptin tablets
They are oral diabetes medicines that help control blood sugar levels